Hoshino S, Teramura M, Takahashi M, Motoji T, Oshimi K, Ueda M, Mizoguchi H
Department of Medicine, Tokyo Women's Medical College, Japan.
Int J Cell Cloning. 1989 May;7(3):156-67. doi: 10.1002/stem.5530070303.
We studied the specific binding of 125I-labeled bioactive recombinant human erythropoietin (Epo) to human bone marrow mononuclear cells (BMNC) obtained from normal subjects. The 125I-labeled Epo bound specifically to the BMNC. Scatchard analysis of the data showed two classes of binding sites; one high affinity (Kd 0.07 nM) and the other low affinity (Kd 0.38 nM). The number of Epo binding sites per BMNC was 46 +/- 16 high-affinity receptors and 91 +/- 51 low-affinity receptors. The specific binding was displaced by unlabeled Epo, but not by other growth factors. Receptor internalization was observed significantly at 37 degrees C, but was prevented by the presence of 0.2% sodium azide. These findings indicate that human BMNC possess two classes of specific Epo receptors with characteristics of a hormone-receptor association.
我们研究了125I标记的生物活性重组人促红细胞生成素(Epo)与从正常受试者获得的人骨髓单个核细胞(BMNC)的特异性结合。125I标记的Epo与BMNC特异性结合。对数据进行Scatchard分析显示有两类结合位点;一类是高亲和力(解离常数Kd为0.07 nM),另一类是低亲和力(Kd为0.38 nM)。每个BMNC上Epo结合位点的数量为46±16个高亲和力受体和91±51个低亲和力受体。特异性结合被未标记的Epo取代,但不被其他生长因子取代。在37℃时明显观察到受体内化,但0.2%叠氮化钠的存在可阻止其发生。这些发现表明人BMNC拥有两类具有激素-受体结合特征的特异性Epo受体。